D64.1 Secondary sideroblastic anemia due to disease

Name of the Condition

• Secondary sideroblastic anemia due to disease
• ICD Code: D64.1

Summary

Secondary sideroblastic anemia due to disease is a type of anemia characterized by the body's inability to properly use iron to make hemoglobin, leading to the accumulation of iron in red blood cell precursors (sideroblasts) in the bone marrow. This results in ineffective red blood cell production and anemia, often as a complication of an underlying medical condition.

Causes

The condition is caused by an underlying disease or disorder that disrupts normal heme synthesis or iron metabolism in red blood cell production. Common underlying causes include chronic inflammatory conditions, infections, malignancies, or other systemic diseases that interfere with iron utilization.

Risk Factors

• Chronic inflammatory diseases (e.g., rheumatoid arthritis, inflammatory bowel disease)
• Malignancies (e.g., leukemia, lymphoma)
• Chronic infections (e.g., tuberculosis, HIV)
• Alcohol use disorder
• Exposure to certain toxins or medications

Symptoms

• Fatigue and weakness
• Shortness of breath, especially with exertion
• Pale or jaundiced skin
• Dizziness or lightheadedness
• Rapid or irregular heartbeat
• Cold hands and feet

Diagnosis

Diagnosis involves a complete blood count (CBC) to assess hemoglobin and red blood cell levels, followed by additional tests such as peripheral blood smear, bone marrow aspiration, and iron studies (e.g., serum ferritin, transferrin saturation). The presence of ringed sideroblasts in the bone marrow confirms the diagnosis, and underlying causes are investigated through clinical evaluation and relevant tests.

Treatment Options

Treatment focuses on addressing the underlying disease and managing anemia symptoms. This may include treating the primary condition, blood transfusions for severe anemia, and supportive care. Iron supplementation is generally avoided unless iron deficiency is also present.

Prognosis and Follow-Up

Prognosis depends on the underlying disease and its response to treatment. Regular monitoring of blood counts and iron levels is important to assess response to therapy and detect complications. Follow-up care is tailored to the primary condition and may involve hematologists or other specialists.

Complications

• Iron overload from ineffective erythropoiesis
• Worsening of the underlying disease
• Increased risk of infections
• Cardiovascular complications from chronic anemia

Lifestyle & Prevention

• Manage underlying conditions as directed by healthcare providers
• Avoid excessive alcohol consumption
• Maintain a balanced diet to support overall health
• Follow up regularly with healthcare providers for monitoring

When to Seek Professional Help

Seek medical attention if experiencing persistent fatigue, shortness of breath, dizziness, or other symptoms of anemia, especially if there is a known underlying disease. Prompt evaluation is important to address the underlying cause and prevent complications.

Tips for Medical Coders

When coding D64.1, ensure the underlying disease is documented and supports the diagnosis of secondary sideroblastic anemia. Code assignment should reflect the specific disease causing the anemia, and documentation should clearly link the anemia to the primary condition. Verify that other causes of sideroblastic anemia (e.g., hereditary) are excluded before assigning this code.